Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
NIH scientist Harvey Alter ’56, ’60M (MD) has received the 2020 Nobel Prize in Physiology or Medicine for the discovery of the hepatitis C virus, a breakthrough the Nobel Assembly said “made possible blood tests and new medicines that have saved millions of lives.” He is the 13th Rochester graduate
The Fall 2020 round of the University’s Technology Development Fund (TDF) is now open. The TDF supports UR researchers as they develop their innovations to a more commercial endpoint. Awards are up to $100,000 and support animal testing, prototyping, and other proof-of-concept studies. The fund is open to all faculty,
Institute of Optics research sets record for shortest laser pulse for newly developed technology, work that has important applications in engineering and biomedicine. University of Rochester researchers are setting a new standard when it comes to producing ultrafast laser pulses over a broader range of wavelengths than traditional laser sources. In
National high priority program funds two projects to better understand how coronavirus interacts with proteins in human cells. Two members of the University of Rochester’s Department of Biology have received expedited funding awards from the National Science Foundation (NSF) to study biological processes involved in COVID-19. As labs reopen across
May 27, 2020 Lindsey Valich / lvalich@ur.rochester.edu A person who has a stroke that causes vision loss is often told there is nothing they can do to improve or regain the vision they have lost. But research from the University of Rochester, published in the journal Brain, may offer hope to stroke patients
The city of Rochester and Monroe County have partnered with Common Ground Health to roll out ROC COVID, an online symptom tracker for community residents. Developed by scientists and information technology staff at the University of Rochester Medical Center and Rochester Regional Health, the health screening tool may help prevent
A new study shows that when specific human brain cells are transplanted into animal models of multiple sclerosis and other white matter diseases, the cells repair damage and restore function. The study provides one of the final pieces of scientific evidence necessary to advance this treatment strategy to clinical trials.
The University of Rochester Medical Center has been participating in a clinical trial testing the safety and efficacy of the antiviral drug remdesivir. According to preliminary results released by the National Institutes of Health, the drug is now showing promise in treating adults diagnosed with COVID-19. The study is led by Ann Falsey, a professor in
The University of Rochester has joined together with the University of Buffalo and Roswell Park Comprehensive Cancer Center to form Empire Discovery Institute, a new drug discovery partnership. EDI aims to convert the institutions’ scientific breakthroughs into viable pharmaceuticals for commercialization and to strengthen the region as a hub for
Precision medicine is saving lives, but Harris A. (Handy) Gelbard, director of Center for Neurotherapeutics Discovery at URMC, believes we’re overlooking another class of extremely important treatment candidates: multi-target drugs. In STAT News, he shares his views on why U.S.-based pharmaceutical companies should pay closer attention to these drugs—including a promising
The groundbreaking work of three scholars with ties to the University of Rochester took center stage when pioneering laser scientist Donna Strickland ’89 (PhD) and her Rochester advisor Gerard Mourou formally received the Nobel Prize in Physics, and Paul Romer, whose early career tenure-track appointment was in Rochester’s Department of